Showing 38,141 - 38,160 results of 173,031 for search '(( 0 0 decrease ) OR ( 50 ((((nn decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.29s Refine Results
  1. 38141

    Plasmids information. by Kaitao Zhao (3617825)

    Published 2025
    “…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  2. 38142

    Raw data. by Kaitao Zhao (3617825)

    Published 2025
    “…Results revealed the MRE11–RAD50–NBS1 (MRN) complex as a potential factor. Transiently or stably knockdown of MRE11, RAD50 or NBS1 in hepatocytes before HBV infection significantly decreased viral markers, including cccDNA, while reconstitution reversed the effect. …”
  3. 38143
  4. 38144
  5. 38145

    Table_1_Potential Influence of Anesthetic Interventions on Breast Cancer Early Recurrence According to Estrogen Receptor Expression: A Sub-Study of a Randomized Trial.docx by Mohan Li (7527596)

    Published 2022
    “…As for ER-negative patients, the recurrence risk in the PPA (paravertebral blocks and propofol general anesthesia) group showed no statistical difference compared with the GA (sevoflurane and opioids general anesthesia) group (19.1% versus 23.4%; adjusted HR: 0.80, 95% CI: 0.50–1.30; P = 0.377). In the first 18 months after breast cancer surgery, which is considered as the classical early peak of recurrence, after adjustment for menstruation and the pathological stage of tumor, the decrease of early recurrence observed in the PPA group was not significant compared with the GA group (adjusted HR: 0.63, 95% CI: 0.34–1.14; P = 0.127).…”
  6. 38146
  7. 38147
  8. 38148
  9. 38149
  10. 38150

    Participant inclusion flowchart. by Shakila Meshkat (12360623)

    Published 2024
    “…In both unadjusted and adjusted models, participants with depressive symptoms had lower odds of FS (aOR = 0.347, 95% CI: 0.307,0.391, p<0.001). Moreover, in both unadjusted and adjusted models, for each 1-point increase in cognitive-affective (aOR = 0.850, 95% CI = 0.836,0.864, p <0.001) and somatic symptoms (aOR = 0.847, 95% CI = 0.831,0.863, p <0.001), odds of high FS decreased correspondingly. …”
  11. 38151

    Demographics of study sample. by Shakila Meshkat (12360623)

    Published 2024
    “…In both unadjusted and adjusted models, participants with depressive symptoms had lower odds of FS (aOR = 0.347, 95% CI: 0.307,0.391, p<0.001). Moreover, in both unadjusted and adjusted models, for each 1-point increase in cognitive-affective (aOR = 0.850, 95% CI = 0.836,0.864, p <0.001) and somatic symptoms (aOR = 0.847, 95% CI = 0.831,0.863, p <0.001), odds of high FS decreased correspondingly. …”
  12. 38152
  13. 38153
  14. 38154

    Antibodies used for flow cytometry. by Shanhe Liu (5251313)

    Published 2025
    “…In AN-LSCs, 75 µM CoCl₂ treatment resulted in a decrease in <i>CASP3</i> (p = 0.049), <i>CASP7</i> (p = 0.041) and <i>BCL2</i> (p = 0.0218) mRNA and Bcl-2 protein levels (p = 0.0405) and an increase of TNF-α protein levels in the cell culture supernatant (p = 0.0251).…”
  15. 38155

    Primer pairs used for qPCR. by Shanhe Liu (5251313)

    Published 2025
    “…In AN-LSCs, 75 µM CoCl₂ treatment resulted in a decrease in <i>CASP3</i> (p = 0.049), <i>CASP7</i> (p = 0.041) and <i>BCL2</i> (p = 0.0218) mRNA and Bcl-2 protein levels (p = 0.0405) and an increase of TNF-α protein levels in the cell culture supernatant (p = 0.0251).…”
  16. 38156
  17. 38157
  18. 38158
  19. 38159
  20. 38160